Flow Cytometry Market

Flow Cytometry Market worth $5.4 billion by 2023

The report "Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, and Region - Global Forecast to 2023" The flow cytometry market is estimated to register a CAGR of 8.2% during the forecast period, to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018. The significant adoption of flow cytometry techniques in research activities & clinical trials, the growing focus on immunology & immuno-oncology research, and the high incidence & prevalence of HIV-AIDS are some of the major factors driving the market for flow cytometry. However, the high cost of flow cytometry instruments and a shortage of skilled professionals are expected to limit market growth during the study period.

Browse 181 market data Tables and 38 Figures spread through 233 Pages and in-depth TOC on "Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, and Region - Global Forecast to 2023"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html

The cell-based flow cytometry segment commanded the largest share of the market in 2018; this trend is expected to continue during the forecast period 

Based on technology, the flow cytometry market is segmented into cell-based and bead-based flow cytometry. Among these, the cell-based flow cytometry segment accounted for the larger market share in 2018. This technology can test compound activity against molecular targets within the context of living cells. Due to this benefit, the adoption of the cell-based flow cytometry technology has increased in the market.

The services segment is expected to witness the highest growth in the flow cytometry market during the study period 

By product & service, the flow cytometry market is segmented into reagents & consumables, instruments, services, software, and accessories. The services segment is likely to portray the highest growth during the forecast period. Flow cytometry services play an essential role in helping end users understand flow cytometry instruments and the cell analysis process. The extensive availability of flow cytometry services is the major factor in driving market growth.

North America was the highest revenue generator of the flow cytometry market in 2018 

The flow cytometry market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America was the highest revenue generator of the flow cytometry market in 2018. The increasing number of drug discovery initiatives by pharmaceutical & biotechnology companies, favorable government support in the form of funds and grants, the rising number of research activities, and the strong presence of major players in this region are supporting the growth of the flow cytometry market in North America.

Some prominent players operating in the flow cytometry market are Becton, Dickinson and Company (US), Beckman Coulter (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Sysmex Partec (Germany), Luminex Corporation (US), Miltenyi Biotec (Germany), Bio-Rad Laboratories (US), Sony Biotechnology (US), and Agilent Technologies (US).

Don’t miss out on business opportunities in Flow Cytometry Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 6015
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Flow Cytometry Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved

Digital Virtual Assistant - MarketsandMarkets